The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 27676469 |
64 |
Phenyltetrazolyl-phenylamides: Substituent impact on modulation capability and selectivity toward the efflux protein ABCG2 and investigation of interaction with the transporter. |
Rheinische Friedrich-Wilhelms-Universit£T Bonn |
| 27376492 |
15 |
New, highly potent and non-toxic, chromone inhibitors of the human breast cancer resistance protein ABCG2. |
Universit£ |
| 27727127 |
16 |
Halogenated naphthochalcones and structurally related naphthopyrazolines with antitumor activity. |
University Bayreuth |
| 27100033 |
40 |
The combination of quinazoline and chalcone moieties leads to novel potent heterodimeric modulators of breast cancer resistance protein (BCRP/ABCG2). |
University Of Bonn |
| 26943020 |
65 |
Pyrrolopyrimidine Derivatives as Novel Inhibitors of Multidrug Resistance-Associated Protein 1 (MRP1, ABCC1). |
University Of Bonn |
| 26774038 |
67 |
Flavonoid derivatives as selective ABCC1 modulators: Synthesis and functional characterization. |
University Of Regensburg |
| 25985195 |
94 |
Potent and Nontoxic Chemosensitizer of P-Glycoprotein-Mediated Multidrug Resistance in Cancer: Synthesis and Evaluation of Methylated Epigallocatechin, Gallocatechin, and Dihydromyricetin Derivatives. |
The Hong Kong Polytechnic University |
| 22822035 |
10 |
Mechanistic studies on the absorption and disposition of scutellarin in humans: selective OATP2B1-mediated hepatic uptake is a likely key determinant for its unique pharmacokinetic characteristics. |
Chinese Academy Of Sciences |
| 23132334 |
28 |
In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor. |
Glaxosmithkline |
| 25855895 |
23 |
HM30181 Derivatives as Novel Potent and Selective Inhibitors of the Breast Cancer Resistance Protein (BCRP/ABCG2). |
University Of Bonn |
| 25311564 |
30 |
Thieno[2,3-b]pyridines--a new class of multidrug resistance (MDR) modulators. |
Institute Of Organic Synthesis |
| 25310383 |
50 |
Potent nonimmunosuppressive cyclophilin inhibitors with improved pharmaceutical properties and decreased transporter inhibition. |
Novartis Institutes For Biomedical Research |
| 25272055 |
18 |
Converting potent indeno[1,2-b]indole inhibitors of protein kinase CK2 into selective inhibitors of the breast cancer resistance protein ABCG2. |
Bmssi Umr 5086 Cnrs/Universit£ |
| 24611893 |
22 |
Symmetric bis-chalcones as a new type of breast cancer resistance protein inhibitors with a mechanism different from that of chromones. |
Bmssi Umr 5086 Cnrs/Universit£ |
| 24184213 |
71 |
Investigation of quinazolines as inhibitors of breast cancer resistance protein (ABCG2). |
University Of Bonn |
| 23851114 |
73 |
Synthesis and biological evaluation of flavones and benzoflavones as inhibitors of BCRP/ABCG2. |
University Of Bonn |
| 23726026 |
12 |
Activity-lipophilicity relationship studies on P-gp ligands designed as simplified tariquidar bulky fragments. |
Universit£ |
| 23374872 |
27 |
Potent and selective tariquidar bioisosters as potential PET radiotracers for imaging P-gp. |
Universit£ |
| 23347803 |
29 |
Naphthalenyl derivatives for hitting P-gp/MRP1/BCRP transporters. |
Universit£ |
| 24900683 |
26 |
Benzanilide-Biphenyl Replacement: A Bioisosteric Approach to Quinoline Carboxamide-Type ABCG2 Modulators. |
University Of Regensburg |
| 15059881 |
1 |
Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro. |
St. Jude Children'S Research Hospital |
| 15313923 |
1 |
Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions. |
The Netherlands Cancer Institute |
| 11437380 |
2 |
Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells. |
Hungarian Academy Of Sciences |
| 15155841 |
6 |
High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter. |
Membrane Research Group Of The Hungarian Academy Of Sciences |
| 16460798 |
2 |
Transport of glyburide by placental ABC transporters: implications in fetal drug exposure. |
Hospital For Sick Children |
| 15007102 |
3 |
HIV protease inhibitors are inhibitors but not substrates of the human breast cancer resistance protein (BCRP/ABCG2). |
University Of Washington |
| 12533678 |
10 |
Reversal of breast cancer resistance protein-mediated drug resistance by estrogen antagonists and agonists. |
Japanese Foundation For Cancer Research |
| 18678495 |
41 |
Structure-activity relationships of new inhibitors of breast cancer resistance protein (ABCG2). |
University Of Bonn |
| 22541068 |
73 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. |
Uppsala University |
| 23017888 |
26 |
4-Substituted-2-phenylquinazolines as inhibitors of BCRP. |
University Of Bonn |
| 22449016 |
6 |
Investigation of chalcones as selective inhibitors of the breast cancer resistance protein: critical role of methoxylation in both inhibition potency and cytotoxicity. |
Bmssi Umr 5086 Cnrs/Universit£ |
| 22366653 |
3 |
Discovery of GS-9451: an acid inhibitor of the hepatitis C virus NS3/4A protease. |
Gilead Sciences |
| 22165858 |
8 |
Substituted chromones as highly potent nontoxic inhibitors, specific for the breast cancer resistance protein. |
Cnrs/Universit£ |
| 20627559 |
6 |
Inhibition of ABCG2-mediated drug efflux by naphthopyrones from marine crinoids. |
Nci-Frederick |
| 19170519 |
34 |
Potent and selective inhibitors of breast cancer resistance protein (ABCG2) derived from the p-glycoprotein (ABCB1) modulator tariquidar. |
University Of Regensburg |
| 18257545 |
34 |
Synthesis and biological evaluation of (hetero)arylmethyloxy- and arylmethylamine-phenyl derivatives as potent P-glycoprotein modulating agents. |
Universita Degli Studi Di Bari |
| 17317193 |
14 |
Acridone derivatives: design, synthesis, and inhibition of breast cancer resistance protein ABCG2. |
Umr 5063 Cnrs/Universit£ |
| 17341062 |
2 |
Nonprenylated rotenoids, a new class of potent breast cancer resistance protein inhibitors. |
Umr 5086 Cnrs/Universit£ |
| 22112540 |
70 |
Investigation of chalcones and benzochalcones as inhibitors of breast cancer resistance protein. |
University Of Bonn |
| 21570282 |
28 |
Solid phase synthesis of tariquidar-related modulators of ABC transporters preferring breast cancer resistance protein (ABCG2). |
Universidad Nacional De Colombia |
| 21275386 |
13 |
Flavonoids from eight tropical plant species that inhibit the multidrug resistance transporter ABCG2. |
National Cancer Institute-Frederick |
| 21189339 |
5 |
Interaction potential of etravirine with drug transporters assessed in vitro. |
University Hospital Heidelberg |
| 21354800 |
77 |
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP). |
University Of Bonn |
| 20097565 |
12 |
Synthesis and structure-activity relationship of botryllamides that block the ABCG2 multidrug transporter. |
Ritsumeikan University |
| 19932960 |
47 |
Novel lead for potent inhibitors of breast cancer resistance protein (BCRP). |
University Of Bonn |
| 19580319 |
40 |
Aromatic 2-(thio)ureidocarboxylic acids as a new family of modulators of multidrug resistance-associated protein 1: synthesis, biological evaluation, and structure-activity relationships. |
University Of Bonn |
| 19053888 |
114 |
2-[(3-Methoxyphenylethyl)phenoxy]-based ABCB1 inhibitors: effect of different basic side-chains on their biological properties. |
Universita Degli Studi Di Bari |
| 28471656 |
91 |
4-Anilino-2-pyridylquinazolines and -pyrimidines as Highly Potent and Nontoxic Inhibitors of Breast Cancer Resistance Protein (ABCG2). |
University Of Bonn |
| 23369356 |
15 |
Biological profile of the less lipophilic and synthetically more accessible bryostatin 7 closely resembles that of bryostatin 1. |
National Cancer Institute-Bethesda |
| 10773045 |
45 |
Characterization of a tropane radioligand, [(3)H]2beta-propanoyl-3beta-(4-tolyl) tropane ([(3)H]PTT), for dopamine transport sites in rat brain. |
Wake Forest University |
| 10755640 |
2 |
18F-labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters. |
Emory University |
| | 35 |
Cycloalkylpiperazines as HIV-1 Protease Inhibitors: Enhanced Oral Absorption |
Merck Research Laboratories |
Search and Browse
